FreeTCCL Archive Galeterone Shows Potential in CRPC AR Variants, Study Says December 01, 2014Vol.37 No.11
FreeTCCL Archive Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm December 01, 2014Vol.37 No.11
FreeTCCL Archive Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis December 01, 2014Vol.37 No.11
FreeTCCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer December 01, 2014Vol.37 No.11
FreeTCCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III December 01, 2014Vol.37 No.11
Free Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light November 26, 2014Vol.40 No.45By Matthew Bin Han Ong
Free Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure November 26, 2014Vol.40 No.45By Matthew Bin Han Ong
FreeIn Brief Tapimmune Inc. and Vaccine & Gene Therapy Institute of Florida form partnership November 21, 2014Vol.40 No.44
FreeIn Brief Dana-Farber Cancer Institute and Astellas Pharma Inc. announce three-year collaboration November 21, 2014Vol.40 No.44
